A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:March 7, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hemophilia ALast Updated:March 7, 2024Not yet recruiting
Condition(s):Severe Hemophilia A Without InhibitorLast Updated:July 20, 2022Completed
Condition(s):Severe Haemophilia ALast Updated:February 23, 2018Completed
Condition(s):Severe Hereditary Factor VIII Deficiency Disease Without Inhibitor; Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor; Haemophilia ALast Updated:May 5, 2022Completed
Condition(s):Hemophilia ALast Updated:March 15, 2024Active, not recruiting
Condition(s):Hemophilia ALast Updated:April 6, 2023Recruiting
Condition(s):Hemophilia ALast Updated:March 27, 2019Completed
Condition(s):Hemophilia ALast Updated:May 15, 2023Active, not recruiting
Condition(s):Hemophilia ALast Updated:March 17, 2021Completed
Condition(s):Hemophilia ALast Updated:February 23, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.